The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.
Pα+ Psychedelic Bulletin #184: Federal Psychedelics Lobbying Jumps 90% in Q3’24, with MDMA-AT the Key Topic – Psychedelic Alpha
In this Issue We explore psychedelics-related lobbying activity at the federal level in Q3’24, which saw a significant increase in such efforts Psychoplastogens a ‘primary